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Air pollution is, increasingly, a concern to our society given the threats to human health and the envi-
ronment. Concerted actions to improve air quality have been taken at different levels, such as through
the development of Air Quality Plans (AQPs). However, air quality impacts associated with the imple-
mentation of abatement measures included in AQPs are often neglected. In order to identify the major
gaps and strengths in current knowledge, a literature review has been performed on existing method-
ologies to estimate air pollution-related health impacts and subsequent external costs. Based on this
review, the Impact Pathway Approach was adopted and applied within the context of the MAPLIA
research project to assess the health impacts and beneﬁts (or avoided external costs) derived from
improvements in air quality. Seven emission abatement scenarios, based on individual and combined
abatement measures, were tested for the major activity sectors (trafﬁc, residential and industrial com-
bustion and production processes) of a Portuguese urban area (Grande Porto) with severe particular
matter (PM10) air pollution problems. Results revealed a strong positive correlation between population
density and health beneﬁts obtained from the assessed reduction scenarios. As a consequence, potential
health beneﬁts from reduction scenarios are largest in densely populated areas with high anthropic
activity and, thus, where air pollution problems are most alarming. Implementation of all measures
resulted in a reduction in PM10 emissions by almost 8%, improving air quality by about 1% and
contributing to a beneﬁt of 8.8 million V/year for the entire study domain. The introduction of PM10
reduction technologies in industrial units was the most beneﬁcial abatement measure. This study intends
to contribute to policy support for decision-making on air quality management.
© 2016 Elsevier Ltd. All rights reserved.1. Introduction
Air pollution is a worldwide problem with widely known
harmful effects to human health and the environment. To reverse
or minimize this trend, multiple joint efforts involving government
entities, organizations and citizens have beenmade. The strategy to
reduce these negative effects, particularly in cities where the ma-
jority of the world population lives, it is to deﬁne air quality
improvement policies. In this sense, European Union Member
States are obligated to establish Air Quality Plans (AQPs) for theirzones/agglomerations in accordance with the Air Quality Directive
(AQD; EC, 2008) whenever exceedances of air quality limit values
are recorded. Unfortunately, aspects beyond air quality are not
addressed or quantiﬁed in the vast majority of these plans. When
air quality impacts are analysed, the great research challenge lies in
quantifying the intensity of the adverse effects as well as the
associated costs (DEFRA, 2004). These costs are known as negative
externalities, involving external costs to repair a given reference
situation or avoid welfare losses. A comprehensive economic
analysis starts with a clear identiﬁcation of the involved air pol-
lutants and their effects on different damage categories, including
health impacts, building and material damages, crop and biodi-
versity losses, and ecosystem degradation (van Essen et al., 2011).
Among these damage categories, health impacts caused by air
pollution contribute to the largest part of the external cost
C. Silveira et al. / Journal of Environmental Management 183 (2016) 694e702 695estimates. This ﬁnding is shared by public health experts that link
air pollution, even at current ambient levels, to worsened
morbidity (especially respiratory and cardiovascular diseases) and
premature mortality (e.g. years of lost life) (EC, 2005). Underlying
these issues, a large variety of environmental factors must be pre-
viously analysed, such as overall pollution levels, characterization
of emission sources (e.g. relative contribution by activity sector,
geographic location and height of release points), population
structure (e.g. density and spatial distribution, age groups) and the
meteorological conditions inﬂuencing transport, dispersion and
chemistry of air pollutants (e.g. Holland et al., 2005).
The deﬁnition of air quality management strategies can be aided
by effectiveness, cost-effectiveness and cost-beneﬁt assessments of
emission reduction scenarios (e.g. Carnevale et al., 2012). Effec-
tiveness studies assess the extent to which these scenarios result in
emission reductions and associated air quality improvements. Cost-
effectiveness studies assess, in addition, the monetary costs asso-
ciated with the implementation of these scenarios and, hence,
facilitate the identiﬁcation of those scenarios that achieve emission
reductions and/or air quality improvements at least cost. Finally,
cost-beneﬁt studies assess, moreover, the monetary beneﬁts asso-
ciated with air quality improvements and, therefore, facilitate the
identiﬁcation of those scenarios that provide largest welfare gains.
Monetary costs associated with the implementation of emission
reduction measures and scenarios are, generally, estimated on the
basis of measure implementation rates and corresponding unit
costs (e.g. following the GAINS methodology; IIASA, 2012). The
estimation of the monetary beneﬁts from emission reduction
measures and scenarios is, however, more complex given the
multiple, interacting and uncertain exposure/dose-response re-
lationships as well as economic valuation issues (see Silveira et al.,
2015).
This paper presents a review on the available methodologies for
the quantiﬁcation of air pollution-related health impacts and sub-
sequent external costs as to, in turn, assess emission reduction
scenarios designed in the research project MAPLIA (http://projeto-
maplia.web.ua.pt/). To achieve this goal, the following speciﬁc ob-
jectives are established: i) identify the relevant physical health
impacts and establish exposure-response functions that allow to
calculate the number of attributable cases; ii) identify the different
cost components related to the impacts and estimate their mone-
tary value; and iii) use these data to assess health impacts and
beneﬁts from the implementation of emission abatement mea-
sures/scenarios in a Portuguese urban area (Grande Porto). These
measures are focused on the major sources of PM10 e the air
pollutant that recorded exceedances from air quality limit values
established in the AQD. Finally, weaknesses and recommendations
regarding the economic evaluation of air pollution impacts on
human health are discussed.
2. Health impacts of air pollution
This section presents a summary description of the methodo-
logical assumptions underlying the quantiﬁcation of air pollution-
related health impacts (Section 2.1) and subsequent economic
evaluation of corresponding damages (Section 2.2). Thereafter, an
overview of research studies underpinning these methodologies is
presented (Section 2.3), in particular with respect to the key impact
functions and associated external costs.
2.1. Physical health impacts
Physical health impacts caused by exposure to air pollutants are
expressed through morbidity andmortality indicators, related with
respiratory and cardiovascular diseases. Regarding the mostcommon air pollutants (particulate matter, ozone, sulphur dioxide
and nitrogen oxides), the following health effects are frequently
reported: i) reduction in life expectancy due to acute and chronic
mortality; ii) chronic effects on morbidity, such as bronchitis and
cough in children and asthmatics; and iii) acute effects on
morbidity, namely respiratory and cardiovascular hospital admis-
sions, asthma episodes and restricted activity. This implies three
different types of cause-effect relationships, that are strongest for
particulate matter (PM) as compared to other air pollutants (EHA,
2006; Pervin et al., 2008) and, thus, their effects are better docu-
mented and quantiﬁed (e.g. Mechler et al., 2002; Ruckerl et al.,
2011).
The quantiﬁcation of these health impacts is based on the cor-
relation between exposure and effect, depending on the speciﬁcity
and availability of data andmodels (Holland et al., 2005). Often, due
to unavailability/lack of epidemiological studies based on country
data, exposure-response functions (ERFs) are taken from interna-
tional epidemiological studies that are regarded as reference
studies by the scientiﬁc community. In this context, ERFs based on
relative risk models have been applied to translate air concentra-
tions into health impacts. Numerous studies show that certain
vulnerable groups within a population (e.g. elderly people, children
and those with underlying diseases) have a greater risk of being
affected by air pollutants (Costa et al., 2014; Pervin et al., 2008;
WHO, 2013a).
These ERFs may be linear or non-linear and, either or not,
contain threshold exposure values. Nevertheless, the vast majority
of the available methodologies assumes that the cause-effect rela-
tion is linear, in the form of a Poisson regression, which usually does
not reﬂect the real situation as there is a threshold exposure value
below which the physical impact is no longer felt. Therefore, these
approaches are considered more appropriate for situations in
which the increase in pollutant emissions is marginal and when the
supposed linearity is not violated and, hence, the applicability
domain (i.e. exposure concentration range) of the model should be
clearly stated (Marques et al., 2013; Pizzol et al., 2010).
Adverse health effects occur often within a short time after
exposure (short-term exposure), resulting in acute effects. Never-
theless, it is important to also consider the cumulative exposure
over time (long-term exposure) that result in chronic effects (Costa
et al., 2014). Short-term exposure studies usually explore time-
series of hourly and daily changes in air pollution, and daily
death counts or cause-speciﬁc hospitalizations (Ruckerl et al.,
2011). Long-term exposure studies assess the increase in mortal-
ity risk due to chronic exposure to air pollution (Seethaler et al.,
2003; WHO, 2013a). To design the overall effect of air pollution
on life expectancy, cohort studies have been used to provide results
in terms of changes in mortality risk (age-speciﬁc death rates) per
unit change in pollutant concentration. For impact estimation, this
change in mortality risk can be most reliably represented using life
table methods to express mortality impacts in the target popula-
tion, translated in terms of life expectancy changes and/or in total
life-years gained or lost for a given air pollution scenario (Hurley
et al., 2005a).2.2. Economic evaluation of impacts
The economic valuation of health impacts arising from air
pollution is, generally, based on the cost-of-illness (COI) approach
(see Pervin et al., 2008; WHO, 2008). According to the COI
approach, total health costs (Chealth) are determined by the sum of
direct (Cdirect), indirect (Cindirect) and intangible (Cintangible) costs
(Pervin et al., 2008):
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Direct costs include health care and non-health care costs
associated with treatment and caring. These costs are based on
market values for e.g. medical staff, examinations, laboratory tests,
medication, consumables and hospital facilities as well as for
caregivers' time, and are estimated using bottom-up or top-down
accounting methods (Pervin et al., 2008).
Indirect costs include costs associated with loss of productivity
due to morbidity as well loss of production due to morbidity or
mortality. These costs are based on market values for e.g. wages,
incomes and earnings, and are estimated using the human capital
approach (HCA) or the friction cost approach (FCA) (Hanly et al.,
2012; Pervin et al., 2008). The HCA approach assesses an in-
dividual's productivity and production losses from health deterio-
ration, based on the time foregone from productive activities over
the individual's lifetime and against the relevant wage rate
(Tranmer et al., 2005). The FCA approach assesses a ﬁrm's pro-
ductivity and production losses from health deterioration, based on
the time needed to restore initial production levels (friction period)
and assuming vacancies are ﬁlled by unemployed (low opportunity
cost) employees (Koopmanschap and van Ineveld, 1992).
Finally, intangible costs include non-market costs associated
with pain and suffering. These costs are based on non-market
values for pain and suffering from morbidity and mortality, and
are estimated using quality-adjusted-life-year (QALY) and
willingness-to-pay (WTP) or willingness-to-accept (WTA) ap-
proaches (Hammitt, 2007). The QALY approach assesses the change
in QALYs, and corresponding monetary values, due to an expected
change in health (Pizzol et al., 2014). Estimates are invariably
dependent on life expectancy, future health and latency, though
rarely dependent on income or risk characteristics (Hammitt,
2007). The “willingness-to” approaches assess an individual's
willingness to spend money for an expected health improvement
(WTP; compensating variation) or, alternatively, an individual's
willingness to receive money to forgo an expected health
improvement (WTA; equivalent variation). Estimated values may
be a function of income, education and age as well as environ-
mental quality (Hammitt, 2007; Seethaler et al., 2003).2.3. Overview of the research studies
This section compiles scientiﬁc/technical information for
different health indicators (i.e. extent of health effects) associated
with air pollution. For the reasons outlined in Section 2.1, only
health effects associated with particulate matter (PM2.5 and PM10)
are presented (Table 1). Note, however, that health effects caused
by other air pollutants (e.g. ozone and nitrogen oxides) should not
be overlooked when the goal is to make a comprehensive health
impact assessment. For each health indicator the following aspects
are considered: affected age groups, exposure time, impact func-
tions (as relative risk) and damage costs per unit.
Largest relative risk impacts from PM air pollution are associ-
ated with cough, asthma, cardiovascular hospital admissions, as
well as cardiopulmonary mortality. External costs due to morbidity
are largest for bronchitis, congestive heart failure and respiratory
and cardiovascular hospital admissions. In relation to mortality
costs, they vary between 21 and 77 thousand Euro per case for
adults over 30 years of age. Hence, it is expected that largest
external costs from PM air pollution are associated with cardio-
vascular health problems.
For certain health indicators the pollutant effect on a given age
group reveals considerable variation in terms of exposure-response
functions (i.e. ERFs) and external costs, which can be explained bythe differing methodologies, the geographical coverage and socio-
economic conditions across studies. The research studies reported
in Table 1 are designed for Europe as a whole (e.g. Brandt et al.,
2013; WHO, 2013b), while some studies are country speciﬁc (e.g
DEFRA, 2013; Seethaler, 1999).
The variability in ERFs may be associated with several factors,
namely the population structure (density, affected age groups and
their distribution), source of data gathering, and unavailability or
improper format of routinely gathered health indicator data for use
in economic evaluations. In addition, the inclusion/exclusion of
threshold exposure values as well as cumulative effects over time
have contributed to the variation in derived risk functions (Hurley
et al., 2005a).
The variability in external cost estimates is particularly large
when these build on WTP studies. WTP studies are based on in-
terviews in which personal interpretation of the questions as well
as strategic behaviour by respondents can lead to biased outcomes
(Pervin et al., 2008). Furthermore, these values might also depend
on additional variables, such as income and age and, probably,
differ between health effects (WHO, 2008). The WTP approach has
the advantage of acquiring the full range of personal costs associ-
atedwith the disease (Pervin et al., 2008), thereby noting thatmany
of those costs have no market value (Belhaj and Fridell, 2010). As a
consequence, several health effects due to air pollution are often
neglected and, hence, results are probably an underestimation of
the total health costs (WHO, 2008).3. Methodology
The approach adopted for assessing the impacts of atmospheric
emissions on human health is described in Section 3.1. Its appli-
cation is demonstrated in Section 3.2, where different emission
abatement measures/scenarios are evaluated for the case of PM10
air pollution in a Portuguese urban area (Grande Porto).3.1. Impact Pathway Approach
The air pollution impact chain is analysed by relating atmo-
spheric emissions from the main activity sectors to air quality state,
associated physical impacts and, ﬁnally, the monetary value of this
impact (Fig. 1). In this sense, the Impact Pathway Approach (IPA),
designed within the ExternE (External Costs of Energy) project (EC,
2005), is often used by the scientiﬁc community to obtain damage
estimates for different impact categories. Moreover, this approach
allows for the beneﬁt analysis of policy options for air quality
management e understanding avoided external costs as beneﬁts
from air quality improvement (Holland et al., 2005). Miranda et al.
(2015) reviewed the assessment capabilities and modelling tools
used in the development of European air quality plans to evaluate
the effects of emission abatement strategies.
The health impacts arising from air pollution can be estimated
using the Costa et al. (2014) study that describes how health can be
integrated in air quality assessments through exposure and dose-
response functions. Thereby, emphasis will be given to the
following components: physical impacts that consider different
health indicators, and external costs to remediate damages or
prevent productivity losses, pain and suffering. To quantify the
extent of these impacts, the IPA has been applied from a bottom-up
perspective. This methodology requires epidemiological informa-
tion on exposure-response functions (effect estimates) and health
outcome frequencies (mortality and morbidity, prevalence, inci-
dence or person-days) which, combined with the population
exposure to air pollution, provides the number of attributable
cases/days:
Table 1
Epidemiological data and economic evaluation of health effects related to PM2.5 and PM10.
Health effect (pollutant) Age group Study design Relative risk (95% CI) External costs (prices per
unit)
Reference
V (base year) Unit
Morbidity
Cough (PM2.5) Children 0.22 Hurley et al. (2005a)
Adults 0.28 Hurley et al. (2005a)
Children <16 yr 0.45 59 (2006) Day Brandt et al. (2013)
Adults >15yr 0.28 59 (2006) Day Brandt et al. (2013)
Cough (PM10) Children 0.13 Hurley et al. (2005a)
Adults 0.17 Hurley et al. (2005a)
Chronic cough (PM2.5) Children Long-term 3.46E-03 Hurley et al. (2005a)
Chronic cough (PM10) Children Long-term 2.07E-03 Hurley et al. (2005a)
Asthma (PM10) Children 5e19 yr Short-term 0.28 (0.06e0.51) WHO (2013b)
Children <15 yr 0.44 (0.27e0.62) Seethaler (1999)
Adults 15 yr 0.39 (0.19e0.59) Seethaler (1999)
31 Day Seethaler et al. (2003)
85 (2000) Day Belhaj and Fridell (2010)
Acute bronchitis (PM10) Children Short-term 131 Day Seethaler et al. (2003)
Bronchitis (PM10) Children <15 yr 3.06 (1.35e5.02) Seethaler (1999)
Children 6e18 yr Long-term 0.8 (0e1.9) WHO (2013b)
Chronic bronchitis (PM2.5) Adults Long-term 3.90E-05 Hurley et al. (2005a)
Adults 8.20E-0.5 52,962 (2006) Case Brandt et al. (2013)
Chronic bronchitis (PM10) Adults 2.45E-0.5 Hurley et al. (2005a)
Adults >18 yr Long-term 1.17 (0.40e1.89) WHO (2013b)
Chronic bronchitis incidence (PM10) Adults >27 yr 0.98 (0.09e1.94) Seethaler (1999)
Adults >27 yr 2.65E-0.5 153,000 (2002) Case Maibach et al. (2008)
Adults 168,840 (2000) Case Belhaj and Fridell (2010)
209,000 Case Seethaler et al. (2003)
190,000 Case Holland et al. (2005)
Congestive heart failure (PM2.5) Over 65 3.09E-05 Hurley et al. (2005a)
3.09E-05 16,409 (2006) Case Brandt et al. (2013)
Congestive heart failure (PM10) Over 65 1.85E-05 Hurley et al. (2005a)
Over 65 3360 (2000) Case Belhaj and Fridell (2010)
Respiratory HA (PM2.5) All ages 3.46E-06 Hurley et al. (2005a)
All ages Short-term 0.19 (0e0.40) WHO (2013b)
3.46E-06 7931 (2006) Case Brandt et al. (2013)
Respiratory HA (PM10) All ages 2.07E-06 Hurley et al. (2005a)
All ages 7.03E-03 1900 (2002) Case Maibach et al. (2008)
All ages 0.13 (0.01e0.25) Seethaler (1999)
Short-term 0.08 3313e13,633 (2012) Case DEFRA (2013)
Respiratory HA All ages 4400 (2000) Case Belhaj and Fridell (2010)
1604 (2003) Case DEFRA (2004)
Cardiovascular HA (PM2.5) All ages Short-term 0.091 (0.017e0.166) WHO (2013b)
Cardiovascular HA (PM10) All ages 4.34E-06 1900 (2002) Case Maibach et al. (2008)
All ages 0.13 (0.07e0.19) Seethaler (1999)
All ages Short-term 0.08 3822e12,614 (2012) Case DEFRA (2013)
All ages Short-term 0.06 (0.03e0.09) Hurley et al. (2005a)
All ages Short-term 0.09 (0.04e0.15) Ballester et al. (2006)
Cardiovascular HA 5106 (2003) Case DEFRA (2004)
Mortality
Lung cancer (PM2.5) 1.3 (0.4e2.2) Case Mechler et al. (2002)
1.26E-05 21,152 (2006) Case Brandt et al. (2013)
Respiratory mortality (PM10) All ages Short-term 0.13 (0.05e2.0) WHO (2008)
Cardiopulmonary mortality (PM2.5) Adults >30 yr Long-term 0.8 (0.2e1.4) Case Mechler et al. (2002); WHO (2008)
Cardiovascular mortality (PM10) All ages Short-term 0.09 (0.05e1.3) WHO (2008)
Acute mortality (PM2.5) 0.068 Hurley et al. (2005a)
Acute mortality (PM10) 0.04 Hurley et al. (2005a)
Chronic mortality (PM2.5) Adults >30 yr 1.138E-0.3 77,199 (2006) YOLL Brandt et al. (2013)
Chronic mortality (PM10) All ages 4.00E-04 40,300 (2002) Case Maibach et al. (2008)
44,595 (2012) Case DEFRA (2013)
Total mortality - All causes (PM2.5) Age >9 months 6.68E-06 3,167,832 (2006) Case Brandt et al. (2013)
Adults >30 yr Long-term 0.6 (0.2e1.0) 63,447 Case Mechler et al. (2002); WHO (2008)
Adults >30 yr Long-term 0.62 (0.40e0.83) WHO (2013b)
Total mortality - All causes (PM10) Age <1 yr Long-term 0.4 (0.2e0.7) WHO (2013b); WHO (2008)
Adults >30 yr 0.43 (0.26e0.61) Seethaler (1999); WHO (2008)
All ages Short-term 0.123 (0.045e0.201) WHO (2013b)
Notes:
- Relative risk per mg m3/person.
- Brandt et al. (2013), Hurley et al. (2005a), Maibach et al. (2008) used the ExternE impact functions (baseline annual rate included in RR).
For long-term studies annual mean concentrations are often used; for short-term studies daily PM means are used.
- HA ¼ Hospital admissions; YOLL ¼ Years of life lost.
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Fig. 1. Different stages leading to the evaluation of emission impacts.
(source: Silveira et al., 2015).
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where DRi is the response as a function of the number of the un-
favorable implications (cases, days or episodes) over all health in-
dicators (i ¼ 1, …, n) avoided or not, Iref is the baseline morbidity/
mortality annual rate, CRFi,p is the correlation coefﬁcient between
the pollutant p's concentration variation and the probability of
experiencing or avoiding a speciﬁc health indicator i (i.e. relative
risk), DCp is the change in the pollutant p's concentration, and
where pop are the population units per age group exposed to
pollutant p.
The concentration of air pollutants and population data are
combined to estimate human exposure and, in turn, the impact
coefﬁcient (CRFi,p) is calculated using an ERF expressed as relative
risk (RR) derived from epidemiological studies. Note that in some
cases the baseline morbidity/mortality rate (Iref) is incorporated in
the CRF (e.g. Brandt et al., 2013; EC, 2005; Wang and Mauzerall,
2006). The resulting physical impacts are translated into mone-
tary values (i.e. external costs), including direct costs, indirect costs
and intangible costs (see Section 2.2; Pervin et al., 2008; Seethaler
et al., 2003).
Emission and air pollution abatement beneﬁt functions are
derived by plotting emission/pollution reductions against corre-
sponding external beneﬁts (i.e. avoided external costs), and esti-
mating corresponding functions using ordinary least squares
techniques (following Roebeling et al., 2009). Emission abatement
beneﬁts (EAB; in million V/year) and air pollution abatement
beneﬁts (PAB; in million V/year) are estimated by:
EAB ¼ a1EA (3a)
PAB ¼ a2PA (3b)
where EA is the emission abatement (% decrease as compared to
current emissions), PA is the air pollution abatement (% decrease as
compared to current air pollution), a1 is the monetary health
beneﬁt from a one percent reduction in emissions, and a2 is the
monetary health beneﬁt from a one percent reduction in air
pollution.
3.2. Application to a Portuguese urban area
The IPA was applied with high spatial resolution to quantifyhealth impacts/beneﬁts from air quality improvement scenarios
due to short for long-term air pollution exposure. The Grande Porto
urban area and neighboring municipalities, located in the north-
west of Portugal (Fig. 2), was selected due to occurrence of air
pollution problems recorded throughout 2012 e in particular PM10
exceedances from air quality limit values established in the AQD
(EC, 2008).
In order to reduce air pollution levels in the study domain,
mainly of PM10, the following emission abatement measures that
are focused on the major activity sectors were analysed along the
impact chain:
1) Replacing 10% of light vehicles below Euro 3 by hybrid vehicles
(HYB);
2) Replacing/reconverting 50% of ﬁreplaces (FIR);
3) Introducing a Low Emission Zone in the city of Porto that bans
the movement of vehicles below Euro 3 (Fig. 2) (LEZ); and
4) Implementation of particle emission reduction technologies
allowing to reduce 10% of PM10 emissions arising from indus-
trial combustion and production processes (IND).
These measures were considered individually and combined,
resulting in 15 emission abatement measures/scenarios that are
assessed with respect to their expected health impacts and bene-
ﬁts. For each abatement measure/scenario the base year emissions
(2012; reference scenario) were recalculated by SNAP (Selected
Nomenclature for Air Pollution) sector according to the measure
type, using preferentially bottom-up approaches. Resulting emis-
sions were used as input data for the TAPM (The Air Pollution
Model; Hurley et al., 2005b), in order to assess the air quality im-
provements based on the reference scenario. The TAPM was
applied with a 1-km2 spatial resolution and 1-h temporal resolu-
tion, and the modelling results were validated against measured
data from air quality monitoring stations, such as Borrego et al.
(2012) made over several Portuguese areas.
Based on the achieved air quality state for the different abate-
ment measures/scenarios, the human health impacts were quan-
tiﬁed using Equation (2). These impacts were analysed through
morbidity and mortality indicators associated with short and long-
term exposure to PM10 concentrations. For each health indicator a
survey of the associated external costs per case/daywas carried out.
Note that the long-term exposure costs were expressed as annual
average costs, taking into account the duration and chronic effects
Fig. 2. Geographic location of the study domain.
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health impacts (ERFs recommended in WHO, 2013b) and subse-
quent external costs (based on Table 1).
Once determined the number of cases and given the costs per
health indicator, the annual beneﬁts (or avoided external costs) to
human health resulting from the implementation of the abatement
measures/scenarios were estimated for the study domain using a 1-
km2 spatial resolution simulation grid.
4. Results and discussion
Results are presented for individual measures (HYB, FIR, LEZ and
IND), combinations of twomeasures (HYBþ FIR and FIRþ IND) and
a scenario including all measures (HYB þ FIR þ LEZ þ IND).
The spatial distribution of total health beneﬁts (Fig. 3) shows a
strong positive correlation between population density and health
beneﬁts (in V/year) obtained from the assessed reduction sce-
narios. It means, therefore, that potential health beneﬁts of
reduction scenarios are largest in densely populated areas (marked
in blue on maps) with high anthropic activity and, thus, where airTable 2
Input data used for quantifying health impacts and external costs associated with PM10
Health effect Age group Study design R
Asthma 5 - 19 yr Short-term 0.
Heart failure >65 yr Short-term 1.
Chronic bronchitis (incidence) >18 yr Long-term 1.
Chronic bronchitis (prevalence) 6-18 yr Long-term 0.
Total mortality <1 yr Long-term 0.
Note: Costs were updated to the base year (2012).pollution problems are most alarming. Moreover, these abatement
measures are focused on the main activity sources that are mostly
concentrated in urban centers and, hence, air quality improve-
ments are more signiﬁcant in these air pollution hotspots. The
largest health beneﬁts from PM10 level improvements are obtained
in the Grande Porto municipalities, in particular Porto, Matosinhos,
Maia and Vila Nova de Gaia. The exception is the LEZ scenario,
whose effects and health beneﬁts are limited to the inﬂuence area
of the proposed LEZ in Porto.
Considering the entire study domain, a positive linear correla-
tion is observed between the average air quality improvement and
the total health beneﬁts for the assessed abatement measures/
scenarios (Fig. 4). This linearity occurs due to simpliﬁed arithmetic
operation used to calculate the health impacts (Eqn. (2)), keeping
the exposed population and the impact functions as spatially con-
stant elements to all scenarios. Fig. 4 clearly shows what reduction
scenarios contribute most to air quality improvement in the study
domain. Regarding the implementation of individual measures, the
industry scenario (IND) is most effective to abate PM10 air pollution
levels (average improvement of 0.61%) while the Low Emissionabatement measures/scenarios.
elative risk (%) Baseline annual rate (%) Cost (V) Unit
28 17 115 Day
85E-05 Included in RR 18,538 Case
17 0.39 18,970 Year
8 18.6 18,970 Year
4 0.163 1844 YOLL
Fig. 3. Spatial distribution of total health beneﬁts (in V/yr) estimated for PM10 abatement measures/scenarios.
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(almost no improvement due to restricted inﬂuence area) in the
Grande Porto area. The abatement scenario combining all measures
(HYB þ FIR þ LEZ þ IND) leads to a reduction in PM10 air pollution
of almost 1% (0.97%), corresponding to an expected health beneﬁt
of 8.8 million V/year.
Similarly, albeit slightly less signiﬁcant, a positive linear corre-
lation is observed between the total PM10 emission reduction andthe total health beneﬁts for the assessed abatement measures/
scenarios (Fig. 5). This discrepancy is related to the fact that air
quality is not only determined by emissions, but also by the phys-
ical and chemical processes involved. Nevertheless, the PM10
emission reduction beneﬁts are closely related to the PM10 air
quality improvement beneﬁts for the assessed abatement mea-
sures/scenarios e roughly in the ratio of eight to one. Again, the
industry scenario (IND) is most effective (reduction of 4.34%) while
Fig. 4. Air pollution abatement rates (PA; in % decrease from base) and beneﬁts (PAB;
in mV/yr) for PM10 abatement measures/scenarios in Grande Porto.
Fig. 5. Emission abatement rates (EA; in % decrease from base) and beneﬁts (EAB; in
mV/yr) for PM10 abatement measures/scenarios in Grande Porto.
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reasons previously mentioned (reduction close to 0%). For the
combined abatement scenario (HYB þ FIR þ LEZ þ IND), a PM10
emission reduction of almost 8% was estimated (7.42%) e corre-
sponding to the abovementioned expected health beneﬁt of 8.8
million V/year.5. Conclusions
In this study the health impacts related to air pollution were
addressed, given the growing societal concern associated with
alarming levels of air pollution and corresponding cases of mor-
tality and morbidity. Firstly, a review on the available methodolo-
gies for the quantiﬁcation of these impacts and subsequent external
costs was carried out and, in turn, the effectiveness and health
beneﬁts from emission abatement measures/scenarios were
assessed using the Impact Pathway Approach.
Economic evaluation studies on air pollution impacts employ
several techniques to estimate the economic costs and beneﬁts
resulting from air quality changes. The key issues to estimate health
costs derived from air pollution are broadly related with two
different concerns: i) how to identify all physical impacts, and ii)
how these impacts can be converted in monetary values. Althoughmany studies have been developed to address these issues, none of
them is complete given that they omit some measurable cost
components and have limitations with respect to the methods used
in estimating damage costs. In order to overcome these methodo-
logical weaknesses, further research is essential to improve the
health impact assessments related with air pollution e contrib-
uting to decrease associated uncertainties. The following priority
areas are commonly recognized by the scientiﬁc community:
- to explore human exposure at the personal level and in different
microenvironments;
- to investigate the health impact due to exposure to multiple
pollutants (cocktail effect);
- to improve monetary valuation of health impacts through
empirical studies that aim to assess the cost elements inte-
grating individual WTP; and
- to improve the coverage of potentially important effects in cost-
beneﬁt studies of air pollution control programs.
This study is aligned with the last research recommendation, as
air quality improvement strategies are proposed to assess health
impacts and beneﬁts. Nevertheless, the positive effects of these
abatement measures/strategies are often underestimated because
there are associated health implications beyond those health in-
dicators here analysed. On the other hand, it is important keeping
in mind that the implementation of emission abatement measures/
strategies produces beneﬁc effects on the reduction of multiple-
pollutant concentrations and, consequently, the beneﬁts extend
to other damage categories, such as ecosystems, biodiversity, crops,
buildings and materials.
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